35629879|t|Type 2 Deiodinase Thr92Ala Polymorphism Is Not Associated with Cognitive Impairment in Older Adults: A Cross-Sectional Study.
35629879|a|Background: Type 2 Deiodinase (DIO2) converts thyroxine (T4) into the active hormone triiodothyronine (T3). Thr92Ala DIO2 polymorphism has been associated with reduced conversion of T4 into T3 and central nervous system hypothyroidism. However, how Thr92Ala DIO2 polymorphism affects cognitive function is still unclear. Objective: To assess the association between Thr92Ala DIO2 polymorphism and cognitive performance in older adults. Design: Cross-sectional study. Setting: University-based tertiary hospital in Brazil. Patients: > 65-year-old with no limiting clinical disease. Interventions: All participants answered a standard questionnaire before undergoing thyroid function laboratory evaluation and genotyping of the Thr92Ala DIO2 polymorphism. Main Outcomes: Cognitive impairment measured by the Word List Memory task from the Consortium to Establish a Registry for Alzheimer's Disease Neuropsychological Battery (CERAD-NB) and the Brief Cognitive Screening Battery (BCSB). Results: A hundred individuals were included. Clinical and laboratory characteristics were similar among DIO2 genotypes (all p > 0.05). No differences were found in the Word List Memory, recall, or recognition tests of the CERAD-NB assuming a recessive model for the Ala/Ala vs. Thr/Ala-Thr/Thr genotypes. Results of Clock Drawing Test, Animal Fluency Test, Mini-Mental State Exam, and Figure Memory Test of the BCSB were similar between groups. Conclusions: These findings suggest that Thr92Ala DIO2 polymorphism is not associated with relevant cognitive impairment in older adults.
35629879	18	26	Thr92Ala	ProteinMutation	tmVar:p|SUB|T|92|A;HGVS:p.T92A;VariantGroup:0;CorrespondingGene:1734;RS#:225014;CorrespondingSpecies:9606;CA#:7292659
35629879	63	83	Cognitive Impairment	Disease	MESH:D003072
35629879	157	161	DIO2	Gene	1734
35629879	172	181	thyroxine	Chemical	MESH:D013974
35629879	211	227	triiodothyronine	Chemical	MESH:D014284
35629879	229	231	T3	Chemical	MESH:D014284
35629879	234	242	Thr92Ala	ProteinMutation	tmVar:p|SUB|T|92|A;HGVS:p.T92A;VariantGroup:0;CorrespondingGene:1734;RS#:225014;CorrespondingSpecies:9606;CA#:7292659
35629879	243	247	DIO2	Gene	1734
35629879	316	318	T3	Chemical	MESH:D014284
35629879	323	360	central nervous system hypothyroidism	Disease	MESH:D007037
35629879	375	383	Thr92Ala	ProteinMutation	tmVar:p|SUB|T|92|A;HGVS:p.T92A;VariantGroup:0;CorrespondingGene:1734;RS#:225014;CorrespondingSpecies:9606;CA#:7292659
35629879	384	388	DIO2	Gene	1734
35629879	492	500	Thr92Ala	ProteinMutation	tmVar:p|SUB|T|92|A;HGVS:p.T92A;VariantGroup:0;CorrespondingGene:1734;RS#:225014;CorrespondingSpecies:9606;CA#:7292659
35629879	501	505	DIO2	Gene	1734
35629879	648	656	Patients	Species	9606
35629879	852	860	Thr92Ala	ProteinMutation	tmVar:p|SUB|T|92|A;HGVS:p.T92A;VariantGroup:0;CorrespondingGene:1734;RS#:225014;CorrespondingSpecies:9606;CA#:7292659
35629879	861	865	DIO2	Gene	1734
35629879	895	915	Cognitive impairment	Disease	MESH:D003072
35629879	1002	1021	Alzheimer's Disease	Disease	MESH:D000544
35629879	1215	1219	DIO2	Gene	1734
35629879	1377	1384	Ala/Ala	ProteinMutation	tmVar:p|SUB|A||A;VariantGroup:1;CorrespondingGene:1734;CorrespondingSpecies:9606
35629879	1393	1400	Ala-Thr	ProteinMutation	tmVar:p|SUB|A||T;VariantGroup:2;CorrespondingGene:1734;CorrespondingSpecies:9606
35629879	1597	1605	Thr92Ala	ProteinMutation	tmVar:p|SUB|T|92|A;HGVS:p.T92A;VariantGroup:0;CorrespondingGene:1734;RS#:225014;CorrespondingSpecies:9606;CA#:7292659
35629879	1606	1610	DIO2	Gene	1734
35629879	1656	1676	cognitive impairment	Disease	MESH:D003072
35629879	Association	MESH:D007037	RS#:225014;HGVS:p.T92A;CorrespondingGene:1734
35629879	Comparison	MESH:D013974	MESH:D014284
35629879	Association	MESH:D007037	1734
35629879	Association	MESH:D013974	1734
35629879	Association	MESH:D014284	1734
35629879	Association	MESH:D007037	1734

